Literature DB >> 14586686

Colchicine therapy in amyloid nephropathy due to recessive dystrophic epidermolysis bullosa.

Kazunari Kaneko, Tomonosuke Someya, Risako Ohtaki, Takako Shimojima, Yuichiro Yamashiro, Yoshiyuki Ohtomo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14586686     DOI： 10.1007/s00467-003-1310-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  5 in total

1.  Reversal of the nephrotic syndrome by colchicine in amyloidosis of familial Mediterranean fever.

Authors:  D Zemer; A Livneh; P Langevitz
Journal:  Ann Intern Med       Date:  1992-03-01       Impact factor: 25.391

2.  Renal amyloidosis in recessive dystrophic epidermolysis bullosa.

Authors:  K Kaneko; M Kakuta; Y Ohtomo; T Shimizu; Y Yamashiro; H Ogawa; M Manabe
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

3.  Colchicine for familial Mediterranean fever.

Authors:  S E Goldfinger
Journal:  N Engl J Med       Date:  1972-12-21       Impact factor: 91.245

4.  Familial Mediterranean fever and amyloidosis.

Authors: 
Journal:  Kidney Int       Date:  1981-11       Impact factor: 10.612

5.  Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever.

Authors:  Ayşe Oner; Ozlem Erdoğan; Gülay Demircin; Mehmet Bülbül; Leyla Memiş
Journal:  Pediatr Nephrol       Date:  2003-04-16       Impact factor: 3.714
  5 in total
  2 in total

Review 1.  Colchicine in Managing Skin Conditions: A Systematic Review.

Authors:  Stefano Dastoli; Steven Paul Nisticò; Pietro Morrone; Cataldo Patruno; Antonio Leo; Rita Citraro; Luca Gallelli; Emilio Russo; Giovambattista De Sarro; Luigi Bennardo
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

2.  Kidney and Urinary Tract Involvement in Epidermolysis Bullosa: Is Routine Follow-Up Necessary?

Authors:  Neslihan Cicek; Nurdan Yildiz; Ruslan Asadov; Ayse Deniz Yucelten; Halil Tugtepe; Harika Alpay
Journal:  Dermatol Pract Concept       Date:  2021-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.